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This work encompassed synthesis and characterization of biocompatible hyperbranched 
polyester drug delivery systems prepared with fumaric acid, glycerol and polyethylene glycol. 
The polymers were manufactured in the melt utilizing A2 + CB2 polymerization.  The ratio of 
A2:CB2 was modified and excess B was added to end-cap the polymers to avoid cross-linking.  
Fumaric acid was selected as the A2 monomer because the double bond provided a site for 
polymer backbone modification or covalent attachment of active pharmaceutical ingredients.  
Acetaminophen and Ondansetron Hydrochloride were added to evaluate feasibility of using the 
polyesters as drug delivery systems. The weight average molecular weight of the A2 + CB2 
polymer systems with the end-capping agent ranged from 5100 to 8500 Da with PDI values 
between 1.3 and 1.7.  The polymers containing Acetaminophen appeared to degrade while the 
































































































LIST OF TABLES 
Table 1:  Gelation summary............................................................................................................. 26 
Table 2:  Molecular weight summary of polymers with different PEG. .......................................... 38 
                                
 
 




















































Linear-dendritic Hybrid Dendrimer-like Star Dendronized Polymer
Hyperbranched Polymer-
grafted Linear


































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































PEG Mn (Da)  Mw (Da)  Mn (Da)  PDI  DB 
350  5100  2900  1.7  0.66‐0.69 
750  5200  3200  1.6  0.65‐0.69 
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